Wednesday, December 11, 2019

Latest:

From my perspective: Dr. Jeremy Schraw shares his experiences during postdoctoral training
School of Health Professions graduation 2019: By the numbers
Healthy Habits: Dr. Zachary Pallister focuses on adequate sleep, family time
Why Houston isn’t immune from the opioid epidemic
Immune checkpoint therapy for ER+ breast cancers, a missed opportunity?

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

Jennifer Blumenthal-Barby

PolicyWise

Should we treat patients with experimental Ebola drugs?

August 13, 2014October 7, 2016 Momentum 0 Comments Audrey M. Marks, Baylor College of Medicine, Center for Medical Ethics and Health Policy, Ebola, ethics, Healthcare, Jennifer Blumenthal-Barby, ZMapp

In the face of the Ebola outbreak plaguing West Africa, an experimental treatment is being administered to patients. However, medical

From the Labs wraps up the Image of the Month feature for the year by presenting a slideshow with the top six most viewed images in 2019.

Listen to the Body of Work Podcast

Body of Work, the Baylor College of Medicine podcast, is an exploration of health topics in the news and important scientific matters featuring insights from experts at Baylor. Listen on your preferred platform.